[1] Barnes PD, Marr KA. Aspergillosis: spectrum of disease, diagnosis, and treatment[J]. Infect Dis Clin North Am, 2006, 20(3): 545-561.
[2] 汪长生, 杨进孙, 都郭蕾. 肺结核并发肺部真菌感染的易感因素分析[J]. 中国防痨杂志, 2010, 32(7): 380-383.
[3] 朱小敏, 周新, 蔡逸婷, 等. 血清半乳甘露聚糖检测对器官移植术后侵袭性肺曲霉病的诊断价值[J]. 中国抗感染化疗杂志, 2005, 5(4): 215-217.
[4] Ascioglu S, Rex JH, De Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus[J]. Clin Infect Dis, 2002, 34(1): 7-14.
[5] De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer/invasive fungal infections cooperative group and the national institute of allergy and infectious diseases mycoses study group (EORTC/MSG) consensus group[J]. Clin Infect Dis, 2008, 46(12): 1813-1821.
[6] Whiting P, Rutjes AW, Reitsma JB, et al. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews[J]. BMC Med Res Methodol, 2003, 3: 25.
[7] Collins J, Müller NL, Kazerooni EA. CT findings of pneumonia after lung transplantion[J]. AJR Am J Roentgenol, 2000, 175(3): 811-818.
[8] 姚婉贞. 侵袭性肺曲霉病的诊断与治疗[J]. 中华结核和呼吸杂志, 2007, 30(11): 812-814.
[9] Leeflang MM, Debets-Ossenkopp YJ, Visser CE, et al. Galactomannan detection for invasive aspergillosis in immunocompromized patients[J]. Cochrane Database Syst Rev, 2008, 4: CD007394.
[10] Zandijk E, Mewis A, Magerman K, et al. False-positive results by the platelia Aspergillus galactomannan antigen test for patients treated with amoxicillin-clavulanate[J]. Clin Vaccine Immunol, 2008, 15(7): 1132-1133.
[11] Pfeiffer CD, Fine JP, Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis[J]. Clin Infect Dis, 2006, 42(10): 1417-1427.
[12] Nguyen MH, Jaber R, Leather HL, et al. Use of bronchoalveolar lavage to detect galactomannan for diagnosis of pulmonary aspergillosis among nonimmunocompromised hosts[J]. J Clin Microbiol, 2007, 45(9): 2787-2792.

[1]	. [J]. Laboratory Medicine, 2023, 38(7): 692-695.
[2]	FANG Yongmei, ZHANG Yan, XU Xueying, ZHONG Feng. Correlation of Staphylococcus aureus drug resistance with drug resistance genes and virulence genes [J]. Laboratory Medicine, 2023, 38(4): 357-361.
[3]	LIU Congcong, LI Jiaping, ZHOU Hongwei. Performance evaluation of 2 mass spectrometry systems in clinical microbial identification [J]. Laboratory Medicine, 2022, 37(11): 1084-1088.
[4]	. [J]. Laboratory Medicine, 2022, 37(10): 952-954.
[5]	LI Renqiang, LUO Junfeng, CHEN Yundi. Establishment and evaluation of α-thalassemia and β-thalassemia mutation determinations using hetero-tail dual-labeled fluorescent probe hydridization [J]. Laboratory Medicine, 2022, 37(10): 955-962.
[6]	BAO Hailin, HUA Hongyan, SUN Hengliang, LIU Hua, JI Shunnian, QIN Chenhao, DU Hong. Rapid identification of carbapenemase producing Enterobacteriaceae phenotypes by modified Carba Np test and mCIM/eCIM test [J]. Laboratory Medicine, 2022, 37(10): 963-968.
[7]	YANG Xi, SONG Wenqi, DONG Fang, MENG Qingying, ZHEN Jinghui, ZHOU Wei. Application of Gram staining and MALDI-TOF MS in the rapid identification of pathogen kinds in children's positive blood culture [J]. Laboratory Medicine, 2022, 37(10): 969-973.
[8]	WANG Lixin, SU Yunfu, WANG Yi. Research progress on the drug resistance mechanism of clinical pathogens to fosfomycin [J]. Laboratory Medicine, 2022, 37(10): 993-997.
[9]	YANG Xiaolan, HU Zengjun, WANG Shengqing, MA Shuxia, ZENG Yongjie, WANG Chenglei. Distribution of some common intestinal bacteria in elderly patients with acute cerebral infarction and its correlation with cognitive function [J]. Laboratory Medicine, 2022, 37(9): 839-843.
[10]	HAO Jiahui, YANG Zehua. Research progress of bacterial integron determination methods [J]. Laboratory Medicine, 2022, 37(9): 887-891.
[11]	LI Kun, ZHANG Guojun. Research progress of carbon quantum dots and graphene quantum dots in sensing field [J]. Laboratory Medicine, 2022, 37(8): 787-792.
[12]	CHEN Hanlu, WU Shenghai. Influence factors of blood culture negative results and progress of pathogen detection in bloodstream infection [J]. Laboratory Medicine, 2022, 37(7): 688-694.
[13]	DU Jinghui, HUANG Zikun, LIU Min, GONG Jingjing, WANG Dan, LIU Jibo, LIU Xu. Rapid determination of minimum inhibitory concentration and cut-off concentration of Mycobacterium tuberculosis by nitrate reductase assay using liquid medium [J]. Laboratory Medicine, 2022, 37(6): 568-576.
[14]	WEN Qinghui, LI Fengying, LI Yanchang, HUANG Jinyin, WANG Fengping. Drug susceptibility of multidrug-resistant ESBL-producing Escherichia coli to antimicrobial agents restored by different concentrations of EDTA [J]. Laboratory Medicine, 2022, 37(3): 205-208.
[15]	CHU Minjun, LI Xiaojuan, HUANG Hailin, LI Jue, MA Mingbiao, DU Tingyi, WANG Haiping. Influence of delayed entry on fastidious bacterium culture in 2 blood culture systems [J]. Laboratory Medicine, 2022, 37(3): 209-212.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics